Population pharmacokinetic characterization of BAY 81‐8973, a full‐length recombinant factor VIII: lessons learned [FIGURE DASH] importance of including samples with factor VIII levels below the quantitation limit
D. Garmann; S. McLeay; A. Shah; P. Vis; M. Maas Enriquez; B.A. Ploeger
Author Information: Bayer AG
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.